• About FESCA
  • Our Members
  • Affiliates
  • Scleroderma research
  • News & Events
  • World Scleroderma Day
  • Contact us
  • Cookie Policy
  • Privacy Statement
  • Disclaimer
FESCA
Phase 2 clinical study for patients with dcSSc or PAH

Phase 2 clinical study for patients with dcSSc or PAH

December 21, 2017 | Clinical trials

The American company, Cumberland Pharmaceuticals, is conducting a phase 2 clinical study evaluating the safety and effectiveness of a new oral drug product.

Recent news

  • 2022 highlights
  • Are you living with diffuse scleroderma?
  • This is Living!
  • Our newsletter for 2021 is out!
  • Public access to medical records – why is progress so slow?

News archive

  • March 2023
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • June 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • January 2020
  • November 2019
  • June 2019
  • April 2019
  • February 2019
  • September 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • December 2017
  • May 2017
  • November 2016
  • September 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • May 2015
  • March 2015
  • February 2015
  • November 2014
  • September 2014
  • July 2014
  • June 2014
  • May 2014
  • March 2014
  • February 2014
  • December 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • June 2009

connect with us

 

Send us a message Send us a message

Like us on Facebook Like us on Facebook

Follow us on Twitter Follow us on Twitter

Follow us on Instagram Follow us on Instagram

Subscribe on Youtube Subscribe on Youtube

 

Legal disclaimer →
Data Protection Policy →

Donate today

 

Federation of European Scleroderma Associations aisbl

Rue du Pont à Rieu 13 i
7500 Saint Maur
Belgium

Federation of European Scleroderma Associations (FESCA )
© 2020 FESCA. Federation of European Scleroderma Associations is an International Non-Profit Association registered in Belgium with Registration No. FOJ 15454
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}